New Molecular Screening Assay Technology Gains Traction NEW HAVEN, CT, (April 3, 2019) – Specialty diagnostics [...]
NEW HAVEN, CT, (March 11th, 2019) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), issues the following [...]
Conference Call to be held Thursday February 21st, 2019 at 4:30pm Eastern Time NEW HAVEN, [...]
Shareholder call scheduled for February 21st at 4:30PM EST NEW HAVEN, CT, (February 14th, 2019) – [...]
One of Nation’s Premier Hospitals to Become Central Laboratory for Liquid Biopsies NEW HAVEN, CT, [...]
Department of Defense Approves Precipio as a Vendor for its Liquid Biopsy Testing NEW HAVEN, [...]
Commercialization of assay underway with both in-house testing and hospital sales NEW HAVEN, CT, (January [...]
Key Metrics Indicate Continued Growth QoQ for Fourth Quarter 2018 NEW HAVEN, CT, (December 12th, [...]
NEW HAVEN, CT, (December 4th, 2018) – Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it [...]
Conference Call to Be Held Monday, November 19, 2018 at 5:00 PM ET NEW HAVEN, [...]
No products in the cart.
Return to shop
Username or email address *
Remember me Log in
Lost your password?